Abstract Submission for ISC 2018 opens soon!
May 10, 2017 – Aug. 1, 2017
Late-breaking clinical trials, late-breaking basic science, & ongoing clinical trials:
Sept. 27, 2017 – Oct. 25, 2017
Why You Should Attend
This 2½-day conference features more than 1,500 compelling presentations in 21 categories that emphasize basic, clinical and translational sciences as they evolve toward a better understanding of stroke pathophysiology with the goal of developing more effective therapies.
This conference provides the opportunity to network with more than 4,500 colleagues in the stroke field from around the world with wide-ranging expertise and experience.
The International Stroke Conference is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease. Clinical Sessions focus on community risk factors; emergency care; acute neuroimaging; acute endovascular and acute nonendovascular treatment; diagnosis of stroke etiology; cerebral large artery disease; in-hospital treatment; clinical rehabilitation and recovery; and health services, quality improvement, and patient-centered outcomes.
Basic Science Sessions focus on vascular biology in health and disease; basic and preclinical neuroscience of stroke recovery; and experimental mechanisms and models. Further specialized topics include pediatric stroke; intracerebral hemorrhage; nursing; preventive strategies; vascular cognitive impairment; aneurysms; subarachnoid hemorrhage; neurocritical care; vascular malformations; and ongoing clinical trials.
Presentations on these topics attract a wide range of healthcare professionals and investigators including adult and pediatric neurologists; neurosurgeons; neuroradiologists and interventional radiologists; physiatrists; emergency medicine specialists; primary care physicians; hospitalists; nurses and nurse practitioners; rehabilitation specialists; physical, occupational, and speech therapists; pharmacists; and basic researchers spanning the fields of cerebrovascular function and disease.
|Feb. 20||Submission site opens for suggested session ideas for ISC 2018 and the Nursing Symposium 2018|
|Feb. 22||Nominations for 2018 Feinberg, Sherman and Willis Awards open|
|March 20||Submission site closes for suggested session ideas for ISC 2018 and the Nursing Symposium 2018|
|May 10||General abstract submission opens|
|July 6||Nominations for 2018 Feinberg, Sherman and Willis Awards Close|
|Aug. 1||11:59 p.m. CDT – General abstract submission closes|
|Sept. 13||FAHA/VIP Registration and housing opens|
|Sept. 20||EARLY Member registration and housing opens|
|Sept. 27||Nonmember registration and housing opens|
|Sept. 27||Late-breaking clinical trials, Late-breaking basic science, and ongoing clinical trials abstract submission opens|
|Sept. 27||Group/Exhibitor housing and registration open|
|Oct. 25||11:59 p.m. CDT – Late-breaking clinical trials, Late-breaking basic science, and ongoing clinical trials abstract submission closes|
|Dec. 5||Deadline to register for EARLY registration rates|
|Dec. 6||ADVANCE registration rates apply|
|Jan. 2||Deadline for ADVANCE registration rate|
|Jan. 3||Standard Registration Rates apply|
|Jan. 23||State-of-the-Science Stroke Nursing Symposium 2018|
|Jan. 23||ISC Pre-Conference Symposia 2018|
|Jan. 24–26||International Stroke Conference 2018 Scientific Sessions|
Add our calendar to yours!
Program and Learning Objectives
- Identify recent advances in basic models of stroke and their translation to clinical research.
- Evaluate recent advances in the diagnosis, treatment, prevention and rehabilitation of cerebrovascular disease.
- Analyze new and ongoing advances in clinical research through late-breaking science and ongoing clinical trials sessions.
- Discuss new research, treatments and interventions with scientists and investigators working in all areas of cerebrovascular disease.
- Interpret the rapidly changing areas within the stroke spectrum such as emerging options for the diagnosis and treatment of acute stroke, mechanisms of stroke recovery, and the impact of vascular cognitive impairment.
- Appraise the diverse challenges presented by cerebrovascular disease to specific populations, including ethnic and racial minorities, women, children, and developing communities.
Policies & Procedures
Following is a list of key policies and procedures strongly enforced at the International Stroke Conference.
Wearing Your Badge
For your safety and security, all attendees, exhibitors, staff and suppliers are required to wear their badge to have access to the American Stroke Association’s International Stroke Conference.
Loss of Badge Credentials
The American Stroke Association reserves the rights to revoke or deny attendance of any registered participant, speaker, exhibitor, news media reporter or photographer of presentations or activities at AHA/ASA scientific conferences and meetings.
Registration Fee Policy
The American Stroke Association will not refund registration fees paid if a person joins at one member level, registers accordingly and then later upgrades to another member level with a lower registration fee. Similarly, no refunds will be given to anyone who registers in one category and then later submits verification to receive a discounted rate.
Policy of Recording
Unauthorized recording of the AHA Scientific Sessions, scientific conferences and the AHA/ASA International Stroke Conference is prohibited, whether by video, still or digital photography, audio or any other recording or reproduction mechanism. This includes recording of presentations and supporting audiovisual materials, poster presentations and supporting poster materials. The American Heart Association and America Stroke Association reserve the rights to all recordings or reproductions of presentations at AHA/ASA scientific conferences and meetings. Check the program for information about the availability of videotapes or audiotapes for purchase. Exceptions to this policy prohibition are:
- Audiotape recording for strictly personal and non-commercial use is permitted if not disruptive; and exhibitors may photograph their own booth for promotional purposes upon prior written consent of the AHA/ASA.
During the International Stroke Conference, attendees, vendors, guests and others may be photographed and videotaped by AHA/ASA vendors in capturing the event. Some of these photographs or videos may be displayed by the AHA/ASA in future publications or materials connected with the event. If you do not wish for your image to be displayed by the AHA/ASA, please contact the AHA/ASA in writing at 7272 Greenville Avenue, Dallas, TX 75231, Att: International Stroke Conference Meetings Department, no later than two weeks after the meeting - March 10, 2017.
Exhibit Hall: The AHA/ASA does not allow children between 6 months to 16 years of age in the Exhibit Hall at any time. Infants under 6 months will be allowed in the Exhibit Hall during show days only. For insurance, liability and safety, infants must be held at all times; strollers and infant carriers will not be allowed. Parents are required to sign a liability waiver before taking an infant into the Exhibit Hall, and badges will need to reflect that a waiver has been signed. Waivers will be available at the family-member registration area.
Education Sessions: Because of the professional nature of the program and limited seating, children are not allowed into scientific presentations.
Poster Hall: For safety reasons, children are not permitted in the Poster Hall.
Lost and Found
If you lose or find an item, please go to the International Stroke Conference Show Office.
The American Stroke Association policy prohibits smoking in all areas of the convention center and all hotel meeting rooms hosting American Stroke Association functions.
- Photos from each day of ISC17
- ISC 2017 ePosters
- ISC 2017 Final Program (PDF)
- ISC 2017 Award Winners (PDF)
- 2017 ISC and Nursing Symposium Abstracts – published in Stroke
- Late-Breaking Science Oral Abstracts: Main Event I (PDF)
- Late-Breaking Science Posters I (PDF)
- Late-Breaking Science Oral Abstracts: Main Event II (PDF)
- Late-Breaking Science Oral Abstracts I (PDF)
- Ongoing Clinical Trials Posters II (PDF)
- Late-Breaking Science Oral Abstracts: Closing Main Event (PDF)